The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Rise In Market Size Of The Viral Genome Sequencing Market During The Forecast Period?

The virtual dissection labs market has experienced rapid growth in recent years. This market is projected to increase from $1.77 billion in 2025 to $2.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.2%. The expansion observed in prior periods can be attributed to the rising adoption of digital learning tools, increasing demand for anatomy visualization, shortage of physical cadavers, growth in medical and veterinary education, and the integration of simulation software in curriculum.

The virtual dissection labs market is anticipated to experience substantial growth in the upcoming years, projected to reach $4.67 billion by 2030 with a compound annual growth rate (CAGR) of 21.5%. This expansion during the forecast period can be attributed to the broadening of cloud-based virtual labs, advancements in AI and AR/VR technologies, increasing adoption in K-12 and higher education, the demand for personalized learning experiences, and investment in content customization and analytics. Major trends identified for this period include interactive 3D anatomical simulations, AR/VR-based collaborative learning, AI-powered assessment and analytics, cloud-based virtual dissection platforms, and customizable curriculum integration.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=24703760&type=smp

Which Strategic Drivers Are Supporting The Viral Genome Sequencing Market Development?

The rising incidence of infectious diseases is anticipated to fuel the expansion of the viral genome sequencing market in the future. These diseases, originating from pathogenic microorganisms, are continually increasing worldwide, driven by factors like greater international travel, urbanization, and the swift transnational spread of pathogens. Consequently, this escalating burden of illness has prompted governments and healthcare infrastructure to enhance their genomic surveillance and outbreak response capacities. Viral genome sequencing is crucial in managing infectious diseases, as it facilitates the quick identification of viral strains, monitors genetic changes, traces transmission routes, and aids in focused public health initiatives. As an illustration, the Centers for Disease Control and Prevention (CDC), a US government agency, reported in February 2026 that influenza led to roughly 290,000–450,000 hospitalizations and 34,000–53,000 deaths each year in the United States. Meanwhile, RSV was responsible for an estimated 190,000–350,000 hospitalizations and 10,000–23,000 deaths. Thus, the rising occurrence of infectious diseases is anticipated to stimulate the expansion of the viral genome sequencing market.

Which Segment Groups Define The Viral Genome Sequencing Market Landscape?

The viral genome sequencing market covered in this report is segmented –

1) By Sequencing Technology: Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing

2) By Sample Type: Blood, Nasal Or Throat Swabs, Saliva, Other Sample Types

3) By Application: Clinical Diagnostics, Research, Epidemiology, Vaccine Development, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Next-Generation Sequencing: Sequencing By Synthesis, Ion Semiconductor Sequencing, Reversible Terminator Chemistry Sequencing, Targeted Amplicon Sequencing, Whole Genome Shotgun Sequencing

2) By Sanger Sequencing: Capillary Electrophoresis Sequencing, Automated Fluorescent Chain Termination Sequencing, Dideoxy Chain Termination Sequencing, Low Throughput Mutation Verification Sequencing, Plasmid Insert Verification Sequencing

3) By Third-Generation Sequencing: Single Molecule Real Time Sequencing, Nanopore Based Sequencing, Zero Mode Waveguide Sequencing, Long Read Direct Ribonucleic Acid Sequencing, Real Time Field Deployable Sequencing

What Trends Are Affecting The Viral Genome Sequencing Market Dynamics?

Leading companies in the viral genome sequencing market are concentrating on technological advancements in long-read sequencing, particularly benchtop long-read sequencing platforms, to achieve a competitive advantage. A benchtop long-read sequencing platform is an integrated laboratory system designed to generate highly accurate, extended nucleotide reads from viral genomes within a compact footprint. This enables comprehensive structural variant detection, improved genome assembly, and a faster turnaround for pathogen characterization, thereby strengthening surveillance capabilities, supporting outbreak response, and enhancing research precision, albeit requiring higher capital investment and advanced data analysis infrastructure at scale. For instance, in November 2024, Pacific Biosciences, a US-based biotechnology company, unveiled the Revio benchtop HiFi sequencing platform. This platform provides high-fidelity long reads, increased throughput compared with earlier systems, and offers a scalable configuration for clinical and research laboratories, consequently improving viral mutation tracking and genome completeness within the viral genome sequencing market.

Which Companies Are Engaged In The Viral Genome Sequencing Market Environment?

Major companies operating in the viral genome sequencing market are F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio‑Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.

Access The Complete Viral Genome Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/viral-genome-sequencing-market-report

Which Region Is The Dominant Market In The Viral Genome Sequencing Market?

North America was the largest region in the viral genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Viral Genome Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample_request?id=24703760&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.